SAA1 and serum lipopolysaccharide activity: Recently, we used SAA-targeted antisense oligonucleotide (ASOSAA) on a high-fat diet-induced obesity model and identified SAA as an additional trigger driving endotoxemia, weight gain and insulin signaling impairment [4].